~ Third Quarter Revenue of $190.7 Million ~

~ EPS of $0.75 and Adjusted EPS of $1.04 ~

~ Raises Fiscal 2018 Outlook ~

~ Board Declares Quarterly Dividend ~

PARAMUS, N.J.--(BUSINESS WIRE)--Movado Group, Inc. (NYSE:MOV) today announced third quarter results for
the period ended October 31, 2017.

America B2C E-Commerce Market 2017" report has been added to Research
and Markets' offering.

and Handheld Gaming Software - Global Strategic Business Report"
report has been added to Research and Markets' offering.

LACHEN, Switzerland--(BUSINESS WIRE)--2017: Octapharma is pleased to announce the completion of a charitable
donation of 30.5 million international units of its human cell-line
derived recombinant factor VIII product, Nuwiq®, in
collaboration with Project

UNAIDS must audit number of people on treatment; AHF says claim of 21
million on treatment could actually be 18 million or less if assumptions
are wrong.

Award Presented as Part of the Chamber's 2017 Annual Awards Gala
November 18

TriLinc Global Impact Fund announced today that it has approved an
additional $17.1 million in term loans and trade finance facilities to
companies operating in Latin America and Southeast Asia, bringing total
financing commitments as of October 31, 2017 to $391 million for
business expansion and socioeconomic development through its holdings in
Sub-Saharan Africa, Latin America, and Southeast Asia.

All ten episodes—featuring an all-star cast including Steve Buscemi,
Bryan Cranston, Greg Kinnear, Anna Paquin, Terrence Howard, Maura
Tierney, Janelle Monáe, Richard Madden, Liam Cunningham, Vera Farmiga,
Juno Temple, Essie Davis, Benedict Wong, Annalise Basso, Mireille Enos,
Rachelle Lefevre and Executive Producers Ronald D. Moore, Michael
Dinner, David Kanter and Bryan Cranston—will be available globally in
select territories on Prime Video

Agreement allows TV Catarina to tap into Intelsat’s global
distribution network to reach audiences in the Brazilian southern state
of Santa Catarina

Oral, Once-Daily Medication ZYTIGA®
(abiraterone acetate) ® Plus
Prednisone / Prednisolone Now Approved in Newly
Diagnosed High-Risk Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)